Hypertension in children and adolescents. II. Drug therapy.
D000367:Age Factors; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001795:Blood Pressure Determination; D002648:Child; D002740:Chlorothiazide / Q000627:therapeutic use; D002908:Chronic Disease; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D005292:Ferricyanides / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000150:complications; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008750:Methyldopa / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D000959:Antihypertensive Agents; D005292:Ferricyanides; D010643:Phenoxybenzamine; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D002740:Chlorothiazide; D012110:Reserpine; D003981:Diazoxide; D010646:Phentolamine; D006145:Guanethidine